Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

Краткое содержание

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.